David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS), sold 33,101 shares at $28.94 ($929K) on 2026-02-12, disclosed to the SEC on 2026-02-13.
Open-market sale of $929k MLYS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.94 | 5,828 | $169K | 18.2% |
| 2 | $28.94 | 5,828 | $169K | 18.2% |
| 3 | $29.64 | 521 | $15K | 1.7% |
| 4 | $29.64 | 521 | $15K | 1.7% |
| 5 | $27.33 | 3,541 | $97K | 10.4% |
| 6 | $27.33 | 4,166 |
| $114K |
| 12.3% |
| 7 | $27.58 | 6,348 | $175K | 18.8% |
| 8 | $27.58 | 6,348 | $175K | 18.8% |
| Total | $28.07 avg | 33,101 | $929K | 100% |
| Filing → |
| MLYS | SELL | 2026-07-15 | $557K | — | Filing → |
| MLYS | SELL | 2026-07-10 | $66K | — | Filing → |
| MLYS | SELL | 2026-06-17 | $350K | — | Filing → |